During the corresponding time, Scienture Holdings Inc sequentially revenue grew by 510.1 %. While revenue at the Scienture Holdings Inc 's corporate clients
Scienture Holdings Inc's Comment on Sales, Marketing and Customers
Scienture LLC operates in the pharmaceutical industry, focusing on markets including hypertension and opioid abuse. The company’s product, Arbli™, is a losartan oral suspension intended for the hypertension market, which comprises treatment options such as ACE inhibitors, ARBs, beta-blockers, diuretics, and calcium channel blockers. The hypertension market includes both branded and generic drugs like Prinvil, Lotensin, Cozaar, Cardizem, Apresoline, Nitrostat, and Toprol-XL. Pending FDA approval, Scienture LLC anticipates that the majority of its product sales will be to pharmaceutical wholesalers, specialty pharmacies, and distributors, who will then supply pharmacies, hospitals, long-term care institutions, and potentially federal and state entities. The company also recognizes opioid abuse as a significant public health issue in the United States, with millions misusing opioids and a high number of drug overdose deaths reported.
Scienture Holdings Inc’s Comment on Sales, Marketing and Customers
Scienture LLC operates in the pharmaceutical industry, focusing on markets including hypertension and opioid abuse. The company’s product, Arbli™, is a losartan oral suspension intended for the hypertension market, which comprises treatment options such as ACE inhibitors, ARBs, beta-blockers, diuretics, and calcium channel blockers. The hypertension market includes both branded and generic drugs like Prinvil, Lotensin, Cozaar, Cardizem, Apresoline, Nitrostat, and Toprol-XL. Pending FDA approval, Scienture LLC anticipates that the majority of its product sales will be to pharmaceutical wholesalers, specialty pharmacies, and distributors, who will then supply pharmacies, hospitals, long-term care institutions, and potentially federal and state entities. The company also recognizes opioid abuse as a significant public health issue in the United States, with millions misusing opioids and a high number of drug overdose deaths reported.
Sources:
Scienture Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Scienture Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Scienture Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
116.28 %